By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bavarian Nordic A/S 

Vesterbrogade 149

Copenhagen    DK-1620  Denmark
Phone: 45-3326-8383 Fax: 45-3326-8380


SEARCH JOBS


Industry
Biotechnology

Segment
Vaccines





Company News
Bavarian Nordic (BAVA.CO) Provides Update On Anticipated Timing Of PROSPECT Study 6/16/2017 10:48:44 AM
Bavarian Nordic (BAVA.CO) Announces Notification Of Request For Proposal For Freeze-Dried IMVAMUNE 6/16/2017 8:59:30 AM
Capital Increase In Bavarian Nordic (BAVA.CO) As A Result Of Employee Warrant Exercise 5/18/2017 11:07:54 AM
Bavarian Nordic (BAVA.CO) Launches Share Buy-Back Program To Hedge Incentive Scheme Obligations 5/18/2017 11:06:45 AM
Bavarian Nordic (BAVA.CO) Announces Appointment Of Dr. Tommi Kainu As Chief Business Officer 5/10/2017 10:59:59 AM
Bavarian Nordic (BAVA.CO) Announces Interim Results For The First Three Months Of 2017 5/4/2017 11:37:01 AM
Bavarian Nordic (BAVA.CO) - Report On The Results Of The Annual General Meeting, Held April 25, 2017 4/25/2017 10:14:55 AM
Bavarian Nordic (BAVA.CO) Announces Initiation Of Phase II Combination Trial Of PROSTVAC, Ipilimumab And Nivolumab In Patients With Localized Prostate Cancer 4/19/2017 7:04:31 AM
Valneva Announces Signing Of A New EB66 Commercial License With Bavarian Nordic (BAVA.CO) 4/18/2017 10:40:39 AM
Bavarian Nordic (BAVA.CO) Announces Collaboration To Evaluate CV301 And Tecentriq In Bladder Cancer 3/10/2017 7:12:55 AM
12345678910...
//-->